Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rifka Schulman-Rosenbaum"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/67b498ec78954fe79294c92e92560883
Publikováno v:
Diabetes Epidemiology and Management, Vol 10, Iss , Pp 100123- (2023)
Aims: The study aimed to identify weight-based insulin requirements for dexamethasone-induced hyperglycemia in COVID-19 infection stratified by hemoglobin A1c (HbA1c). Methods: This retrospective study assessed hospitalized patients ≥ 18 years admi
Externí odkaz:
https://doaj.org/article/5ce5f75b4eeb46a5b0f1050773266233
Publikováno v:
Endocrine Practice. 28:1166-1177
Optimal glucocorticoid-induced hyperglycemia (GCIH) management is unclear. The COVID-19 pandemic has made this issue more prominent because dexamethasone became the standard of care in patients needing respiratory support. This systematic review aime
Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis
Autor:
Daniela Farzadfar, Caitlyn A. Gordon, Keith P. Falsetta, Tori Calder, Adey Tsegaye, Nina Kohn, Rifka Schulman-Rosenbaum
Publikováno v:
Endocrine Practice. 28:787-794
Coronavirus disease 2019 (COVID-19) is thought to contribute to diabetic ketoacidosis (DKA) and worse outcomes in patients with diabetes. This study compared the cumulative insulin dose required to achieve DKA resolution in the intensive care unit am
Publikováno v:
Clinical Thyroidology. 34:183-187
Publikováno v:
Diabetes epidemiology and management.
Autor:
Rifka Schulman-Rosenbaum, Donna Jornsay, Allison Tiberio, Robert Silverman, Elissa Wolff, Frederick Davis, Nina Hadzibabic, Dana Gottlieb, Katherine Cuan
Publikováno v:
Endocrine Practice. 27:1133-1138
Objective Severely uncontrolled diabetes mellitus (DM) is associated with poor long-term outcomes and may remain unrecognized. A high frequency of uncontrolled DM has been identified in the acute-care setting, including the emergency department obser
Autor:
Rifka Schulman-Rosenbaum
Publikováno v:
Endocrine Practice. 29:S33
Autor:
Lori Ohanesian, Benjamin Cohen, Roza Giannakopoulos, Caitlyn Gordon, Lauren McKeon, Rifka Schulman-Rosenbaum
Publikováno v:
Endocrine Practice. 29:S8
Publikováno v:
Journal of the Endocrine Society. 6:A129-A130
Background Cushing syndrome (CS) is a rare endocrinopathy resulting from prolonged exposure to endogenous or exogenous glucocorticoids. CS can be subclinical or can present with an array of overt signs and symptoms. The goal of treatment in CS is to